Medikabazaar, India's leading B2B e-commerce platform for medical supplies, plans to secure $150-$200 million from private equity investors to support its expansion strategy, incorporating both acquisitions and organic growth. Vivek Tiwari, Co-Founder and CEO of Medikabazaar, stated, 'We are actively pursuing a significant investment round to drive our expansion.' He further mentioned the intent to raise a substantial amount, ranging between $150-200 million, within the next six months.

If the planned fundraising comes to fruition, Medikabazaar could potentially join the unicorn club, achieving a valuation of $1 billion. In April 2022, Medikabazaar secured approximately $65 million from Lighthouse India Fund and other investors. According to Tracxn, a startup data platform, Medikabazaar was valued at $641 million in its latest funding round. Vivek Tiwari mentioned that the funding would enable Medikabazaar to explore various acquisition opportunities, including logistic firms, fintechs, technological capabilities, specialty distribution companies, and white label products.

In the fiscal year 2023, Medikabazaar recorded a gross merchandise value (GMV) of around $536 million, resulting in a net revenue of $70-80 million, representing less than 1% of the total GMV. Tiwari stated that Medikabazaar is operating at breakeven, with no apparent cash burn in the business, allowing for a breakeven or slightly positive EBITDA. Tiwari anticipates that Medikabazaar will capture at least 2-3% of the total Indian healthcare medical supplies market in the next five years, translating into a GMV over five times the current levels.